Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmen Cabrera

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Leukemia|March 9, 2018
Early myeloma-related death in elderly patients: development of a clinical prognostic score and evaluation of response sustainability rolePaula Rodríguez-Otero, María Victoria Mateos, Joaquín Martínez-López, et al.
Blood Cancer Journal|March 20, 2019
Predicting long-term disease control in transplant-ineligible patients with multiple myeloma: impact of an MGUS-like signaturePaula Rodríguez-Otero, María Victoria Mateos, Joaquín Martínez-López, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2024
Minimally Invasive Assessment of Peripheral Residual Disease During Maintenance or Observation in Transplant-Eligible Patients With Multiple MyelomaMarta Lasa, Laura Notarfranchi, Cristina Agullo, et al.
Leukemia|March 9, 2019
Correction: Early myeloma-related death in elderly patients: development of a clinical prognostic score and evaluation of response sustainability rolePaula Rodríguez-Otero, María Victoria Mateos, Joaquín Martínez-López, et al.
Blood|April 28, 2016
Minimal residual disease monitoring and immune profiling in multiple myeloma in elderly patientsBruno Paiva, Maria-Teresa Cedena, Noemi Puig, et al.
Hemasphere|April 25, 2025
High-risk features of early relapse in newly-diagnosed multiple myeloma: The impact of cytogenetics and response to initial therapyAndrea Manubens, Bruno Paiva, Norma C Gutiérrez, et al.
Blood Cancer Journal|April 20, 2022
A simple score to predict early severe infections in patients with newly diagnosed multiple myelomaCristina Encinas, José-Ángel Hernandez-Rivas, Albert Oriol, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Leukemia|March 9, 2018
Early myeloma-related death in elderly patients: development of a clinical prognostic score and evaluation of response sustainability rolePaula Rodríguez-Otero, María Victoria Mateos, Joaquín Martínez-López, et al.
Blood Cancer Journal|March 20, 2019
Predicting long-term disease control in transplant-ineligible patients with multiple myeloma: impact of an MGUS-like signaturePaula Rodríguez-Otero, María Victoria Mateos, Joaquín Martínez-López, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2024
Minimally Invasive Assessment of Peripheral Residual Disease During Maintenance or Observation in Transplant-Eligible Patients With Multiple MyelomaMarta Lasa, Laura Notarfranchi, Cristina Agullo, et al.
Leukemia|March 9, 2019
Correction: Early myeloma-related death in elderly patients: development of a clinical prognostic score and evaluation of response sustainability rolePaula Rodríguez-Otero, María Victoria Mateos, Joaquín Martínez-López, et al.
Blood|April 28, 2016
Minimal residual disease monitoring and immune profiling in multiple myeloma in elderly patientsBruno Paiva, Maria-Teresa Cedena, Noemi Puig, et al.
Hemasphere|April 25, 2025
High-risk features of early relapse in newly-diagnosed multiple myeloma: The impact of cytogenetics and response to initial therapyAndrea Manubens, Bruno Paiva, Norma C Gutiérrez, et al.
Blood Cancer Journal|April 20, 2022
A simple score to predict early severe infections in patients with newly diagnosed multiple myelomaCristina Encinas, José-Ángel Hernandez-Rivas, Albert Oriol, et al.
Pageof 7